Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

mAbs

Showing results (1041-1050 of 1,834) with videos related to

Pageof 184
Sort By:
Mabs|February 12, 2013
Qualification of a free ligand assay in the presence of anti-ligand antibody Fab fragmentsRyan J Hansen, Robin M Brown, Jirong Lu, et al.
Mabs|June 15, 2013
Targeting endogenous nuclear antigens by electrotransfer of monoclonal antibodies in living cellsGuillaume Freund, Annie-Paule Sibler, Dominique Desplancq, et al.
Mabs|July 26, 2013
Glycovariant anti-CD37 monospecific protein therapeutic exhibits enhanced effector cell-mediated cytotoxicity against chronic and acute B cell malignanciesSarwish Rafiq, Anthony Siadak, Jonathan P Butchar, et al.
Mabs|September 3, 2013
Knobs-into-holes antibody production in mammalian cell lines reveals that asymmetric afucosylation is sufficient for full antibody-dependent cellular cytotoxicityWhitney Shatz, Shan Chung, Bing Li, et al.
Mabs|September 3, 2013
In-depth qualitative and quantitative analysis of composite glycosylation profiles and other micro-heterogeneity on intact monoclonal antibodies by high-resolution native mass spectrometry using a modified OrbitrapSara Rosati, Ewald T J van den Bremer, Janine Schuurman, et al.
Mabs|August 9, 2013
Characterization and comparison of commercially available TNF receptor 2-Fc fusion protein products: letter to the editorBrian Hassett, Scott McMillen, Brian Fitzpatrick
Mabs|August 9, 2013
Immunogenicity of mAbs in non-human primates during nonclinical safety assessmentPeter J K van Meer, Marlous Kooijman, Vera Brinks, et al.
Mabs|August 9, 2013
Hydroxocobalamin association during cell culture results in pink therapeutic proteinsKenneth M Prentice, Ronald Gillespie, Nathan Lewis, et al.
Mabs|June 20, 2013
Effect of antigen binding affinity and effector function on the pharmacokinetics and pharmacodynamics of anti-IgE monoclonal antibodiesDeborah L Mortensen, Saileta Prabhu, Eric G Stefanich, et al.
Mabs|April 12, 2013
IBC's 23rd Annual Antibody Engineering, 10th Annual Antibody Therapeutics international conferences and the 2012 Annual Meeting of The Antibody Society: December 3-6, 2012, San Diego, CAPeter-Christian Klöhn, Ulrich Wuellner, Nora Zizlsperger, et al.
Pageof 184

Showing results (1041-1050 of 1,834) with videos related to

Sort By:
Pageof 184
Mabs|February 12, 2013
Qualification of a free ligand assay in the presence of anti-ligand antibody Fab fragmentsRyan J Hansen, Robin M Brown, Jirong Lu, et al.
Mabs|June 15, 2013
Targeting endogenous nuclear antigens by electrotransfer of monoclonal antibodies in living cellsGuillaume Freund, Annie-Paule Sibler, Dominique Desplancq, et al.
Mabs|July 26, 2013
Glycovariant anti-CD37 monospecific protein therapeutic exhibits enhanced effector cell-mediated cytotoxicity against chronic and acute B cell malignanciesSarwish Rafiq, Anthony Siadak, Jonathan P Butchar, et al.
Mabs|September 3, 2013
Knobs-into-holes antibody production in mammalian cell lines reveals that asymmetric afucosylation is sufficient for full antibody-dependent cellular cytotoxicityWhitney Shatz, Shan Chung, Bing Li, et al.
Mabs|September 3, 2013
In-depth qualitative and quantitative analysis of composite glycosylation profiles and other micro-heterogeneity on intact monoclonal antibodies by high-resolution native mass spectrometry using a modified OrbitrapSara Rosati, Ewald T J van den Bremer, Janine Schuurman, et al.
Mabs|August 9, 2013
Characterization and comparison of commercially available TNF receptor 2-Fc fusion protein products: letter to the editorBrian Hassett, Scott McMillen, Brian Fitzpatrick
Mabs|August 9, 2013
Immunogenicity of mAbs in non-human primates during nonclinical safety assessmentPeter J K van Meer, Marlous Kooijman, Vera Brinks, et al.
Mabs|August 9, 2013
Hydroxocobalamin association during cell culture results in pink therapeutic proteinsKenneth M Prentice, Ronald Gillespie, Nathan Lewis, et al.
Mabs|June 20, 2013
Effect of antigen binding affinity and effector function on the pharmacokinetics and pharmacodynamics of anti-IgE monoclonal antibodiesDeborah L Mortensen, Saileta Prabhu, Eric G Stefanich, et al.
Mabs|April 12, 2013
IBC's 23rd Annual Antibody Engineering, 10th Annual Antibody Therapeutics international conferences and the 2012 Annual Meeting of The Antibody Society: December 3-6, 2012, San Diego, CAPeter-Christian Klöhn, Ulrich Wuellner, Nora Zizlsperger, et al.
Pageof 184